K Wahlbeck

Summary

Affiliation: University of Helsinki
Country: Finland

Publications

  1. ncbi Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Prog Neuropsychopharmacol Biol Psychiatry 24:911-22. 2000
  2. ncbi Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Am J Psychiatry 156:990-9. 1999
  3. ncbi Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, PB 320, FIN 00029, HUCH, Finland
    Psychiatry Res 93:13-9. 2000
  4. ncbi Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Lappviksvägen, PO Box 320, FIN 00029, Helsinki, Finland
    Arch Gen Psychiatry 58:48-52. 2001
  5. ncbi Efficacy of beta-blocker supplementation for schizophrenia: a systematic review of randomized trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Lappviksvägen, Finland
    Schizophr Res 41:341-7. 2000
  6. ncbi Influence of methodology on outcomes of randomised clozapine trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Pharmacopsychiatry 33:54-9. 2000
  7. ncbi A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Prog Neuropsychopharmacol Biol Psychiatry 21:591-9. 1997
  8. ncbi Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Lappviksvägen, Finland
    Schizophr Res 41:335-40. 2000
  9. ncbi Associations between childhood living circumstances and schizophrenia: a population-based cohort study
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, , PO Box 320, FIN-00029 HUCH Helsinki, Finland
    Acta Psychiatr Scand 104:356-60. 2001
  10. ncbi Dropout rates in randomised antipsychotic drug trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, HUS, Finland
    Psychopharmacology (Berl) 155:230-3. 2001

Detail Information

Publications13

  1. ncbi Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Prog Neuropsychopharmacol Biol Psychiatry 24:911-22. 2000
    ....
  2. ncbi Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Am J Psychiatry 156:990-9. 1999
    ..The purpose of this study was to evaluate all available trial-based evidence on the effectiveness of clozapine in schizophrenia as compared with conventional neuroleptics...
  3. ncbi Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, PB 320, FIN 00029, HUCH, Finland
    Psychiatry Res 93:13-9. 2000
    ..This finding needs replication and further corroboration in well-designed studies...
  4. ncbi Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Lappviksvägen, PO Box 320, FIN 00029, Helsinki, Finland
    Arch Gen Psychiatry 58:48-52. 2001
    ..Nutritional factors in early life may contribute to the neurodevelopmental deficit in schizophrenia. This study explores the influence of maternal body size, size at birth, and childhood growth on future risk for schizophrenia...
  5. ncbi Efficacy of beta-blocker supplementation for schizophrenia: a systematic review of randomized trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Lappviksvägen, Finland
    Schizophr Res 41:341-7. 2000
    ..At present beta-blockers cannot be recommended in the treatment of schizophrenia, and schizophrenia treatment guidelines advocating use of beta-blockers should be revised...
  6. ncbi Influence of methodology on outcomes of randomised clozapine trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Pharmacopsychiatry 33:54-9. 2000
    ..No other quality items correlated to the primary outcomes. Inadequate randomisation techniques may be a source of bias in clozapine studies, but much more research is needed on the connections between trial quality and trial outcome...
  7. ncbi A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Finland
    Prog Neuropsychopharmacol Biol Psychiatry 21:591-9. 1997
    ....
  8. ncbi Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, Lappviksvägen, Finland
    Schizophr Res 41:335-40. 2000
    ..This may be a function of treatment or a result of the deteriorating schizophrenic process...
  9. ncbi Associations between childhood living circumstances and schizophrenia: a population-based cohort study
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, , PO Box 320, FIN-00029 HUCH Helsinki, Finland
    Acta Psychiatr Scand 104:356-60. 2001
    ..Other possible underlying mechanisms of the associations found include infectious and psychological factors...
  10. ncbi Dropout rates in randomised antipsychotic drug trials
    K Wahlbeck
    Department of Psychiatry, University of Helsinki, HUS, Finland
    Psychopharmacology (Berl) 155:230-3. 2001
    ..It has been assumed that new atypical drugs improve treatment compliance due to fewer adverse effects. Data supporting this assumption are scarce...
  11. ncbi Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study
    A Ahokas
    Psychiatric Research Unit, Mehilainen Clinic, University of Helsinki, Finland
    J Clin Psychiatry 62:332-6. 2001
    ..To evaluate the association between estradiol and postpartum depression, we measured serum estradiol concentration and performed an open-label study of physiologic 17beta-estradiol...
  12. ncbi Decrease of energy expenditure causes weight increase in olanzapine treatment - a case study
    M Virkkunen
    Department of Psychiatry, University of Helsinki, Finland
    Pharmacopsychiatry 35:124-6. 2002
    ..Insulin sensitivity did not change. We conclude that decreased basal energy expenditure may contribute to weight gain in olanzapine treatment...
  13. ncbi Actometry in measuring the symptom severity of restless legs syndrome
    K Tuisku
    Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
    Eur J Neurol 12:385-7. 2005
    ..Both our standardized actometric parameters (nocturnal lower limb activity and controlled rest activity) decreased significantly during the intervention in parallel with the subjectively reported relief of RLS symptoms...